Press "Enter" to skip to content

Patent delisted for Veloxis Pharms drug ENVARSUS XR

1
Copyright © DrugPatentWatch. Originally published at Patent delisted for Veloxis Pharms drug ENVARSUS XR

Annual Drug Patent Expirations for ENVARSUS+XR
Envarsus Xr is a drug marketed by Veloxis Pharms Inc and is included in one NDA. It is available from one supplier. There are seventeen patents protecting this drug.

Drug patent litigation for ENVARSUS XR.

This drug has forty-nine patent family members in twenty-four countries.

The generic ingredient in ENVARSUS XR is tacrolimus. One supplier is listed for this compound. Additional details are available on the tacrolimus profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at Patent delisted for Veloxis Pharms drug ENVARSUS XR
Online Certificate Course

Decision-Making for Generic Drug Entry & Branded Drug Lifecycle Management

  • When will key drug patents expire?
  • How can I find, evaluate, and plan for generic market entry opportunities?
  • How can I find proprietary out-of-court settlements and deal terms?
DrugPatentWatch - Make Better Decisions